PFG Investments LLC Purchases New Stake in Astera Labs, Inc. $ALAB

Key Points

• PFG Investments LLC acquired a new stake in Astera Labs, purchasing 2,637 shares valued at approximately $238,000 during the second quarter.
• Astera Labs reported $191.93 million in revenue for the latest quarter, which is a 149.5% increase year-over-year, alongside an earnings per share (EPS) of $0.44, exceeding analyst expectations.
• Institutional investors now hold 60.47% of Astera Labs' stock, and insiders have recently sold a total of 1,492,036 shares valued at around $232.6 million.

PFG Investments LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 2,637 shares of the company's stock, valued at approximately $238,000.

Several other hedge funds have also added to or reduced their stakes in the company. Hoey Investments Inc. lifted its stake in shares of Astera Labs by 4.2% in the 1st quarter. Hoey Investments Inc. now owns 5,000 shares of the company's stock valued at $298,000 after purchasing an additional 200 shares during the period. Sound Income Strategies LLC lifted its stake in shares of Astera Labs by 34.7% in the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock valued at $47,000 after purchasing an additional 204 shares during the period. Allworth Financial LP lifted its stake in shares of Astera Labs by 20.4% in the 1st quarter. Allworth Financial LP now owns 1,394 shares of the company's stock valued at $90,000 after purchasing an additional 236 shares during the period. GAMMA Investing LLC lifted its stake in shares of Astera Labs by 55.7% in the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after purchasing an additional 284 shares during the period. Finally, Wealthcare Advisory Partners LLC lifted its stake in shares of Astera Labs by 1.1% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 28,939 shares of the company's stock valued at $1,727,000 after purchasing an additional 320 shares during the period. Institutional investors own 60.47% of the company's stock.

Astera Labs Stock Performance

Astera Labs stock opened at $200.74 on Monday. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The stock has a market capitalization of $33.37 billion, a P/E ratio of 358.46, a PEG ratio of 5.09 and a beta of 1.43. The stock has a 50-day simple moving average of $189.83 and a 200 day simple moving average of $119.85.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. During the same quarter last year, the company posted $0.13 earnings per share. Astera Labs's quarterly revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ALAB has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft increased their price target on Astera Labs from $160.00 to $200.00 and gave the company a "buy" rating in a research note on Tuesday, September 2nd. TD Cowen initiated coverage on Astera Labs in a research note on Wednesday, October 1st. They issued a "hold" rating and a $200.00 price target on the stock. Weiss Ratings reissued a "hold (c-)" rating on shares of Astera Labs in a research note on Saturday, September 27th. Morgan Stanley raised their price objective on Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a research note on Friday, August 29th. Finally, Wall Street Zen downgraded Astera Labs from a "buy" rating to a "hold" rating in a research note on Friday. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $159.83.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the completion of the transaction, the chief operating officer owned 5,525,545 shares in the company, valued at approximately $939,453,160.90. This trade represents a 4.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total value of $31,708,410.00. Following the transaction, the director owned 385,863 shares of the company's stock, valued at $66,858,482.01. The trade was a 32.17% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,492,036 shares of company stock worth $232,607,552. Company insiders own 12.50% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.